SCHEMBL6253328

SCHEMBL6253328

CNc1nc(N)nc2nc(N)c(-c3ccccc3)nc12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.68
▸ KDM4E B2RXH2 2/20 0.68
▸ MTOR P42345 2/20 0.68
▸ JAK2 O60674 1/20 0.68
▸ GMNN O75496 1/20 0.68
▸ LMNA P02545 1/20 0.68
▸ TP53 P04637 1/20 0.68
▸ CYP1A2 P05177 1/20 0.68
▸ GLA P06280 1/20 0.68
▸ CTSG P08311 1/20 0.68
▸ CYP3A4 P08684 1/20 0.68
▸ GAA P10253 1/20 0.68
▸ CYP2D6 P10635 1/20 0.68
▸ CYP2C9 P11712 1/20 0.68
▸ PKM P14618 1/20 0.68
▸ HPGD P15428 1/20 0.68
▸ TSHR P16473 1/20 0.68
▸ ALOX12 P18054 1/20 0.68
▸ NFKB1 P19838 1/20 0.68
▸ SLC6A2 P23975 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6811031 0.91 PIK3CG (0.64) ALDH1A1KDM4EMTORJAK2GMNN
SCHEMBL14524242 0.82 PIK3CG (0.69) ALDH1A1KDM4EMTORJAK2GMNN
Triamterene SCHEMBL40707 0.81 ALDH1A1 (1.00) ALDH1A1KDM4EMTORJAK2GMNN
Triamterene SCHEMBL29531410 0.81 ALDH1A1 (1.00) ALDH1A1KDM4EMTORJAK2GMNN
Triamterene SCHEMBL5421685 0.81 ALDH1A1 (1.00) ALDH1A1KDM4EMTORJAK2GMNN
Triamterene SCHEMBL11044581 0.80 ALDH1A1 (0.97) ALDH1A1KDM4EMTORJAK2GMNN
Dimethylamine SCHEMBL10566645 0.75 ALDH1A1 (0.69) ALDH1A1KDM4EMTORJAK2GMNN
SCHEMBL10894514 0.74 ALDH1A1 (0.87) ALDH1A1KDM4EMTORJAK2GMNN
SCHEMBL6819013 0.74 NOS1 (0.56) ALDH1A1KDM4ELMNATP53MAPK1
SCHEMBL17407823 0.73 ADORA2A (0.47) ALDH1A1KDM4EPKMMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1216246-B1 N-SUBSTITUTED 4-AMINOPTERIDINES, SYNTHESIS AND USE THEREOF AS PHARMACEUTICAL AGENT VASOPHARM BIOTECH GMBH & CO KG (DE) 2005-08-24 — — EP disclosed
US-6844343-B1 Nitric oxide synthase inhibitors; strokes VASOPHARM BIOTECH GMBH (DE) 2005-01-18 — — US disclosed
EP-1216246-A1 N-SUBSTITUTED 4-AMINOPTERIDINES, SYNTHESIS AND USE THEREOF AS PHARMACEUTICAL AGENT Vasopharm Biotech GmbH & Co. KG (DE) 2002-06-26 — — EP disclosed
WO-2001021619-A1 N-SUBSTITUTED 4-AMINOPTERIDINES, SYNTHESIS AND USE THEREOF AS PHARMACEUTICAL AGENT VASOPHARM BIOTECH GMBH & CO. KG (DE) 2001-03-29 — — WO disclosed
Send feedback